Artificial HMOs mimic mothers’ secret formula
Posted: 18 November 2019 | Claudia M Hüther-Franken (on behalf of Jennewein Biotechnologie), Jennewein Biotechnologie | No comments yet
HMO’s are special sugars that play a crucial role in baby’s development. With biotechnological processes they can be produced on industrial scale.
Human milk oligosaccharides – or HMOs for short – are special sugars that play a crucial role in the development of newborns and toddlers. HMOs are produced only by women in the late stages of pregnancy and breast-feeding mothers. Today however, HMOs can be produced using straight-forward biotechnology processes. One of the pioneers in this field, and a leading manufacturer of artificial HMOs that closely mimic nature, is the German biotech firm Jennewein Biotechnologie.